Sonoma Pharmaceuticals, Inc. (SNOA) earnings
Quarterly results of Sonoma Pharmaceuticals, Inc. as filed with the SEC: revenue, net income and earnings per share for each of the last 8 quarters, the latest results release and when the next one is expected.
Next earnings date
Sonoma Pharmaceuticals, Inc. was expected to report around November 3, 2026; nothing is on file with the SEC yet.
Latest quarter: Q1 FY2027
In Q1 FY2027 (ended June 30, 2026) Sonoma Pharmaceuticals, Inc. reported revenue of $6.4M (+59.6% on the same quarter a year earlier) and a net loss of $330K.
Diluted earnings per share were -$0.09.
Quarter by quarter
| Quarter | Revenue | vs year ago | Net income | EPS |
|---|---|---|---|---|
| Q1 FY2027 | $6.4M | +59.6% | -$330K | -$0.09 |
| Q4 FY2026 | $5.6M | +48.1% | -$581K | - |
| Q3 FY2026 | $4.3M | +22% | -$819K | -$0.48 |
| Q2 FY2026 | $5.6M | +56.6% | -$534K | -$0.32 |
| Q1 FY2026 | $4M | - | -$1.2M | -$0.76 |
| Q4 FY2025 | $3.8M | - | -$776K | - |
| Q3 FY2025 | $3.6M | - | -$928K | -$0.63 |
| Q2 FY2025 | $3.6M | - | -$610K | -$0.59 |
Results filings
- Quarterly report 10-Q
- Annual report 10-K
- Quarterly report 10-Q
When is Sonoma Pharmaceuticals, Inc.'s next earnings date?
Sonoma Pharmaceuticals, Inc. was expected to report around November 3, 2026; nothing is on file with the SEC yet.
What were Sonoma Pharmaceuticals, Inc.'s latest quarterly results?
For Q1 FY2027, which ended June 30, 2026, Sonoma Pharmaceuticals, Inc. reported revenue of $6.4M and a net loss of $330K. The figures come from its filing with the SEC.
Is Sonoma Pharmaceuticals, Inc.'s revenue growing?
Revenue in Q1 FY2027 was $6.4M, up 59.6% from $4M in the same quarter a year earlier.
Get an email when SNOA reports
Follow SNOA and we email you its next results the day they are filed, with the numbers explained.